Validate Turkish involuntary movements scale
- Trial ID
- NCT07023224
- Official Title
- Adaptation Of The Parkinson's Disease Dyskinesia Questionnaire Into Turkish And Its Validity And Reliability In Parkinson's Patient
- Goal
- Validate Turkish involuntary movements scale
- Status
- RECRUITING
- Sponsor
- Izmir Bakircay University
- Study Type
- OBSERVATIONAL
- Enrollment
- 130 participants
- Conditions
- Idiopathic Parkinson Disease, Dyskinesias, Quality of Life
- Interventions
- Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)
Summary For Families
They want to adapt the Parkinson's Disease Dyskinesia Scale (PDYS-26) into Turkish and make sure the translation accurately measures dyskinesias and how those involuntary movements affect quality of life. The team will have people with Parkinson's complete the Turkish PDYS-26 and test its validity and reliability, checking whether responses consistently reflect the frequency, severity, and daily-life impact of dyskinesia so clinicians and researchers can trust the tool. Adults with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who have at least mild dyskinesia on the UPDRS, can give consent, and score 24 or higher on the Mini Mental State Exam are eligible, while those with atypical parkinsonism or major health problems that would affect assessments are excluded.
Locations
- Bakirçay University Çiğli Regional Education Hospital, Izmir, İ̇zmi̇r, Turkey (Türkiye)
- Izmir Bakırçay Univercity, Izmir, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26). They want to adapt the Parkinson's Disease Dyskinesia Scale (PDYS-26) into Turkish and make sure the translation accurately measures dyskinesias and how those involuntary movements affect quality of life. The team will have people with Parkinson's complete the Turkish PDYS-26 and test its validity and reliability, checking whether responses consistently reflect the frequency, severity, and daily-life impact of dyskinesia so clinicians and researchers can trust the tool. Adults with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3 who have at least mild dyskinesia on the UPDRS, can give consent, and score 24 or higher on the Mini Mental State Exam are eligible, while those with atypical parkinsonism or major health problems that would affect assessments are excluded.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 1 month.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.